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Abstract
Background:  It has been suggested that bone loss and cognitive decline are co-occurring
conditions, possibly due to their relationship with estrogen. Cognitive decline has been associated
with various nutritional deficiencies as well. The purpose of this study was to determine if cognitive
function is related to bone mineral density of various skeletal sites as well as to various dietary
components.
Methods: Cross-sectional study with 97 healthy, Caucasian, postmenopausal women (59.4–85.0
years) enrolled in a larger longitudinal study, investigating the effects of sodium on bone mass. The
subjects were divided into two groups based on cognition scores. Group 1 represented lower and
Group 2 higher scores on cognitive function. Bone mineral density from the whole body, lumbar
spine, femur and forearm were measured with the Lunar DPX-MD instrument. Anthropometry
was measured by standard methods. Cognition was assessed using the Mini Mental State
Examination. Cumulative (over 2 years) dietary intake from 3-day records was analyzed by Food
Processor® (ESHA Research, Salem, OR) and cumulative physical activity was assessed using Allied
Dunbar National Fitness Survey for older adults.
Results: Subjects' cognition scores ranged from 22–30 (normal, 27–30), indicating all subjects had
either mild or no cognitive impairment. Multiple Analysis of Covariance adjusted for age, height,
weight, physical activity, alcohol, calcium, sodium and energy intake, showed a statistically significant
association between cognition and bone mineral density of all measurable sites (η2 = 0.21, P < 0.01).
However, after Analysis of Covariance follow-up tests and Bonferroni correction, the differences
for individual bone sites diminished, though Group 2 had higher adjusted means for all sites except
for the femoral neck, Ward's triangle and trochanter. There was a positive significant association
between cognition score and carbohydrate and potassium intake (η2 = 0.07, P = 0.050). Group 2
did have a significantly higher potassium intake (P = 0.023). In multiple regression, saturated fat had
a significant negative relationship with cognitive function.
Conclusions: It appears mild degree of cognitive impairment may be a marker for lower bone
mineral density as well as for a diet lower in carbohydrate and potassium intake, and higher in
saturated fat. Consequently, older women with cognitive impairment may benefit of being screened
for potential bone loss and poor nutrition.
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Background
It is well known that a decline in estrogen is related to
bone loss and possibly a loss in cognitive function as well.
It has been suggested that bone loss and cognitive decline
are co-occurring conditions, likely due to their relation-
ship with estrogen [1,2]. Recent studies suggest estrogen
replacement therapy may benefit cognitive function in
postmenopausal women without memory impairment
[3]. Other studies report estrogen therapy may benefit
women with Alzheimer's disease (AD) [4] or those at risk
for AD [5]. Conversely, studies also report estrogen defi-
ciency is not associated with poor cognitive function [6].
These conflicting results could be due to various reasons,
including the type of cognitive assessment tool, inclusion
(or not) of confounders, degree of cognitive decline, age
of the subjects, to name just a few.
Few studies have examined the relationship between cog-
nitive function and bone mineral density (BMD), both as
possible markers of cumulative estrogen exposure. Two
studies found a positive relationship with total hip BMD
[1,2] and femoral neck BMD [1] and cognitive function in
older adults presumably due to higher cumulative expo-
sure to estrogen [1,2]. Women with osteoporosis were
found to have poorer cognitive function (presumably due
to lower estrogen exposure) [2]. However, both of these
studies used elderly subjects with significant cognitive
impairment and/or history of osteoporotic fractures and
one of them [1] did not control for physical activity, a sig-
nificant predictor of both BMD [7] and cognitive function
[8].
Both cognitive function and BMD also depend on various
nutrients in food. Studies have found elderly people who
performed better on cognitive tests had higher intakes of
energy, fruits, vegetables, fiber, carbohydrate, protein, B-
vitamins, vitamins A and C, calcium, phosphorous and
iron [9-11], and overall better healthy diet score [12]. In
general, it appears a more balanced diet that contains
more vitamins and minerals is associated with better cog-
nitive function. Substantial research in the past decade has
focused on the relationship between antioxidants from
diet and/or supplements and cognitive function. How-
ever, no clear consensus has been reached as to whether
taking antioxidant supplements will help preserve cogni-
tive function and prevent the development of dementia.
Some studies suggest vitamin E [13,14], vitamin C [15]
and beta-carotene [15,16] positively benefit cognitive
function, while other studies have not found a relation-
ship between vitamin E [16,17], vitamin C [13,14,16-18]
or beta-carotene [13,17,18] and cognitive function. There
is also controversy as to whether particular fats in the diet
are beneficial or potentially harmful to cognitive function
due to their relation to the development of atherosclero-
sis, thrombosis, and inflammation of arterial walls
[17,19].
Due to the above inconsistencies and uncertainties in the
literature we investigated cognitive function and its rela-
tionship with bone, as well as with nutrients from both
diet and supplements, in healthy postmenopausal
women with either no or mild cognitive impairment. Our
research questions were as follows: 1) Does bone mass in
various skeletal sites differ by cognitive function among
postmenopausal women when controlling for confound-
ers known to impact bone, such as age, height, weight,
hours of total activity, alcohol consumption and total
energy, sodium and calcium intake? 2) How do various
nutrients in the diet relate to cognitive function in post-
menopausal women when controlling for the above
confounders?
Methods
Subjects
This cross-sectional evaluation included 97 currently non-
smoking, Caucasian, postmenopausal women free of
chronic diseases (including severe osteoporosis) and
medications (including estrogen) known to affect bone.
All subjects reported at least 12 years of education (high
school graduate), with many having additional college
education. Subjects were part of a larger longitudinal
study investigating the effects of a reduced sodium intake
on bone, as described previously [20] and were randomly
asked to participate in this study. Subjects were instructed
to maintain a calcium intake of 1200 mg a day, the current
recommended adequate intake [21], and were given cal-
cium citrate supplements, if necessary, to assure adequate
calcium intake throughout the study (as per the protocol
of a larger study). All data for this study were collected by
one person, a registered dietitian (RAB). The Institutional
Human Subjects Review Board approved study protocol
and subjects signed informed consent.
Anthropometry and bone densitometry
Weight and height were measured by standard procedures
in indoor clothes without shoes. BMD (g/cm2) was meas-
ured by dual X-ray absorptiometry with a Lunar DPX-MD
instrument (GE Medical Systems, Madison, WI, USA)
using specialized software for whole body, lumbar spine,
femur (neck, trochanter, Ward's triangle and shaft) and
forearm (including radius and ulna), as described previ-
ously [22]. The BMD and anthropometries, were meas-
ured every 6 months throughout the study, but only those
obtained at the time when cognition test was given (usu-
ally in a second year of the study) were used in analyses
and in relation to cognitive status. Quality assurance of
our densitometer was performed daily and coefficients of
variation and precision of the instrument were reported
previously [22].BMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/2
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Cognitive assessment
Cognition was assessed using the Mini Mental State Exam-
ination (MMSE) [23]. The MMSE is a brief, commonly
used screening tool to assess cognitive status. It consists of
various graded questions and tasks generating a maxi-
mum of 30 possible points. Each subject was asked a
series of questions from eleven categories; orientation to
time, orientation to place, registration, attention and cal-
culation, recall, naming, repetition, comprehension, read-
ing, writing and drawing. Scores are classified as: normal
cognitive function with a score of 27–30; mild cognitive
impairment with a score of 21–26; moderate cognitive
impairment with a score of 11–20; and severe cognitive
impairment with a score of 0–10 [24]. Cognitive function
for each subject was assessed one time, usually in the sec-
ond year of the study, and evaluated with the correspond-
ing bone and anthropometric measurements conducted
at that time, or with the cumulative average of other vari-
ables of interest.
Dietary and alcohol consumption assessment
Subjects were instructed by a registered dietitian to record
3 days of dietary intake (2 week and 1 weekend day) every
6 months during the study. Food models and pictures
were used for instruction. After the records were com-
pleted, the same dietitian followed-up and rechecked
every record with each participant, particularly about
additional food or snacks consumed, portion sizes, and
ways of preparation. The same dietitian analyzed nutrient
intake from the records using Food Processor® (ESHA
Research, Salem, OR). Mean daily intake, including total
energy and all other macro- and micronutrients (vitamins,
minerals and fatty acids) was calculated. Supplement use
was recorded during each visit, as well. The detailed
description of diet assessment is reported earlier [20].
Cumulative average intake of each considered nutrient, to
the point of the cognition assessment (usually in a second
year), was used to assess its relationship with cognitive
functioning. Alcohol consumption was assessed using
questionnaire designed to determine long-term (at least
for a last year and extending back to several years), fre-
quency, amount, and source of intake, with the help of the
same dietitian. It was expressed as drinks per day, from
which g/day of alcohol was calculated, as described previ-
ously [25].
Physical activity
Physical activity (PA) was assessed using the modified
Allied Dunbar National Fitness Survey for older adults
[26] and was collected every 6 months. A measure of total
activity was assessed based on minutes per week engaged
in weight bearing activities of a moderate intensity
defined as an activity of at least 4 kcal/min, such as recre-
ational activities (tennis, hiking, weight lifting), walking,
heavy housework, gardening and do-it-yourself activities.
Data collected included frequency and duration of each
activity and were expressed as number of hours per week
engaged in the above activities. The questionnaire was
filled with the participants on the site and with the help of
a dietitian. We used this questionnaire in our previous
studies in postmenopausal women and found it reliable
and easy to complete [27]. Cumulative average activity
score to the point of the cognitive assessment was used in
the subsequent analyses.
Data analysis
Data analysis was conducted with SPSS statistical software
(version 8.0). Pearson's r was calculated among all varia-
bles, as a preliminary analysis. To determine the relation-
ship between cognitive function and BMD, subjects were
divided into two groups based on the mean (27.9) for the
MMSE score. Group 1 comprised of subjects below and
group 2 of subjects above the mean. One-way Analysis of
Variance (ANOVA) was conducted for various bone sites
and covariates to determine if there were significant group
differences. Multiple Analysis of Covariance (MANCOVA)
with univariate follow-up tests and Bonferroni corrections
to the alpha level were used to check for group differences
in BMD of the whole body, all sites of the hip (neck, tro-
chanter, Ward's triangle and shaft), lumbar spine and
forearm. Subjects' age, height, weight, hours of total activ-
ity, alcohol consumption and total energy, calcium and
sodium intake were included in the analysis as confound-
ers. The use of these confounders was based on scientifi-
cally proven and theoretically presumed evidence for their
possible effects on bones and memory.
To determine the relationship between cognitive function
and diet, subjects were divided into two groups based on
MMSE criteria for normal cognitive function (score of
≥27). Group 1 (<27), was considered to have mild cogni-
tive impairment while Group 2 (≥27), was considered to
have normal cognitive function. Multiple regression mod-
els were calculated to find the best model using various
nutrients to predict cognitive function. ANOVA was con-
ducted for all nutrients and covariates. MANCOVA with
confounders (described above) and univariate follow-up
tests were used to check for group differences in nutrient
intake. Significance level was set at P ≤ 0.05.
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Results
Cognitive function and BMD
All bone sites, whole body, hip (neck, trochanter, Ward's
triangle and shaft), spine and forearm, were sufficiently
highly correlated with each other, as expected (r ranged
from 0.43–0.98, P = 0.0001), to justify the use of MAN-
COVA for this data set. Subjects' mean MMSE score was
27.9, with a range of 22–30, indicating all subjects had
either mild or no cognitive impairment (Table 1).
Descriptive statistics for each group and all subjects com-
bined are presented in Table 1. ANOVA was conducted to
assess group differences for age, height, weight, total activ-
ity, alcohol consumption, and energy, sodium and cal-
cium intake. Group 2 had significantly higher body
weight (F1,95 = 8.57, P = 0.004) than Group 1, while other
variables of interest were not significantly different.
MANCOVA was conducted for the above groups to deter-
mine the relationship between cognitive function and
BMD for whole body, all sites of the hip, lumbar spine
and forearm. Box-M test was not significant indicating the
observed covariance matrices of the dependent variables
were equal across both groups: Box-M = F(28,15625) =
30.11, P = 0.502. Levene test revealed the error variance of
the dependent variables was equal across both groups, P
ranged from 0.407 to 0.948. MANCOVA results revealed
statistically significant differences between the two groups
of subjects, Wilks' Λ = 0.79, F(7,77) = 2.96, P = 0.009,
multivariate η2 = 0.21. Several of the covariates signifi-
cantly influenced the combined dependent variables:
total activity, Wilks' Λ = 0.79, F(7,77) = 2.93, P = 0.009,
multivariate η 2 = 0.21; weight, Wilks' Λ = 0.73, F(7,77) =
4.11, P = 0.001, multivariate η2 = 0.27; and age, Wilks' Λ
= 0.72, F(7,77) = 4.28, P = 0.001, multivariate η2 = 0.30.
ANCOVA with Bonferroni correction to the alpha level (P,
0.05/7 variables = 0.007) was conducted on each depend-
ent variable as a follow-up test to MANCOVA. The signif-
icance between groups slightly diminished, but the trend
remained. Table 2 lists the adjusted and unadjusted
means of BMD for each group at each bone site. Group 2
had higher unadjusted BMD for all sites except for the
Ward's triangle, and higher adjusted means for all sites
except for the femoral neck, Ward's triangle, and tro-
chanter. Groups were significantly different using Bonfer-
roni correction to the alpha level for several of the
covariates: weight was significantly different for all sites of
the hip BMD; total activity was significantly different for
the femoral neck and Ward's triangle BMD; and age was
significantly different for forearm BMD.
Cognitive function and diet
To explore the relationship between diet and cognitive
function we calculated Pearson's r for all variables. Both
carbohydrate and total potassium intake (food and sup-
plements) were significantly correlated to MMSE score, r =
0.22, P = 0.029 and r = 0.20, P = 0.048, respectively. In a
multiple regression model containing age, height, total
activity, alcohol consumption, and total vitamins B6, B12,
C, A, and E intake, the latter implied in some studies to
having influence on cognition) weight and energy were
positive predictors and saturated fat intake (mean ± SD =
18.8 g ± 8.0 g) was a negative predictor of MMSE, with
multiple R2
adjusted = 0.071.
Subjects were divided into two groups based on MMSE
criteria for normal and impaired cognition, with Group 1
classified as mild cognitive impairment (MMSE score
<27), and Group 2 classified as normal cognitive impair-
ment (MMSE score ≥27). ANOVA was conducted to assess
group differences for age, height, weight, total activity,
alcohol consumption and energy intake. Body weight was
significantly higher in group 2, (F1,95 = 8.57, P = 0.004),
whereas other variables of interest were not different
between groups, P ranged from 0.235 to 0.980.
Table 1: Mean ± SD for descriptive characteristics of all subjects and for each group1
Variable Group 1 n = 34 Group 2 n = 63 All Subjects n = 97
Age 69.7 ± 6.9 69.7 ± 6.7 69.7 ± 6.7
Weight (kg)2 63.9 ± 9.0 70.7 ± 11.9 68.3 ± 11.4
Height (cm) 160.6 ± 6.1 161.6 ± 7.3 161.2 ± 6.9
MMSE score3 25.4 ± 1.5 29.2 ± 0.8 27.9 ± 2.1
Alcohol (drinks/day) 0.4 ± 0.6 0.3 ± 0.5 0.3 ± 0.5
Energy (kcal/day) 1596 ± 252 1645 ± 345 1628 ± 315
Total calcium (food and supplements) (mg/day) 1426 ± 350 1438 ± 279 1434 ± 304
Sodium (mg/day) 2114 ± 661 2322 ± 955 2249 ± 866
Total Activity (hr/wk) 5.4 ± 3.7 6.3 ± 6.0 6.0 ± 5.3
1Groups were stratified to below (Group 1) and above (Group 2) the mean for cognitive function score of 27.9 2statistically significant difference 
between groups, P < 0.01 3 Mini Mental State Examination scoreBMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/2
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MANCOVA for the above groups was conducted to deter-
mine the relationship between cognitive function and car-
bohydrate and total potassium intake, as combined
dependent variables. MANCOVA results revealed a statis-
tically significant difference among the two groups of sub-
jects, Wilks' Λ = 0.93, F(2,86) = 3.11, P  = 0.050,
multivariate  η2 = 0.07. Energy intake was significantly
related to carbohydrate and total potassium intake, Wilks'
Λ = 0.38, F(2,86) = 69.61, P = 0.0001, multivariate η2 =
0.62. ANCOVA was conducted for potassium and carbo-
hydrate as a follow-up test to MANCOVA. After Bonfer-
roni correction to the alpha level (P, 0.05/2 variables =
0.025), total potassium intake was significantly different
between groups, P = 0.023, with multivariate η2 = 0.058.
Table 3 lists the adjusted and unadjusted means of carbo-
hydrate and total potassium intake for each group. Group
2 had higher unadjusted and adjusted means for both var-
iables. Groups were significantly different using Bonfer-
roni correction to the alpha level in energy intake for both
carbohydrate and total potassium intake, P = 0.0001.
Discussion
Our results suggest subjects with lower MMSE scores had
overall lower bone mass than subjects with higher MMSE
scores. MANCOVA results indicated a moderate effect (η2
= 0.21), or 21% of generalized variability in BMD from
the whole body, all sites of hip, spine and forearm is
accounted for by differences in MMSE scores after correct-
ing for subjects' age, height, weight, total activity, alcohol
consumption, and total energy, calcium and sodium
intake. Unadjusted group means were lower in Group 1
(MMSE score <27.9) for all bone sites except the Ward's
triangle (Table 2). However, with the ANCOVA follow-up
tests to MANCOVA the group differences for individual
bone sites diminished. Several of the confounders had a
significant influence on various bone sites, which might
have accounted for the diminished significance with
ANCOVA. Additionally, stronger statistical significance
may have been reached in other bone sites with more sub-
jects in each group.
Our results based on unadjusted means, agree with Yaffe
et al, who also found older women with poor cognitive
function to have lower total hip BMD [2]. Zhang et al,
found elderly men and women with moderate verbal
memory impairment (a measure of cognitive function) to
also have lower femoral neck BMD [1]. Lui at al [28] in a
large prospective cohort study of over 4000 women found
Table 2: Adjusted1 (in bold) and unadjusted means ± SD, with corresponding P values of bone mineral density (BMD) of each bone site 
for two groups2 of subjects
Bone Site (BMD) (g/cm2)G r o u p  1 G r o u p  2 P-values
Femoral Neck 0.825 0.822 0.883
0.795 ± 0.09 0.838 ± 0.12 0.093
Ward's Triangle 0.731 0.678 0.042
0.700 ± 0.11 0.691 ± 0.14 0.820
Trochanter 0.758 0.742 0.776
0.719 ± 0.12 0.761 ± 0.13 0.093
Femoral Shaft 1.036 1.041 0.838
0.999 ± 0.13 1.057 ± 0.17 0.062
Lumbar Spine3 1.082 1.099 0.659
1.057 ± 0.16 1.113 ± 0.21 0.237
Forearm4 0.431 0.445 0.265
0.426 ± 0.05 0.448 ± 0.67 0.173
Whole Body 1.083 1.090 0.672
1.067 ± 0.08 1.098 ± 0.92 0.101
1 Adjusted for age, height, weight, total hours of current activity a week, alcohol consumption, and total energy, calcium and sodium intake, 2Groups 
were stratified to below (Group 1) and above (Group 2) the mean for cognitive function score of 27.9 3BMD of the second, third and fourth lumbar 
vertebrae 4BMD of the ulna and radius
Table 3: Adjusted1 (in bold) and unadjusted means ± SD for 
average intake of carbohydrates and total potassium for two 
groups2 of subjects
Nutrient Group 1 Group 2
Carbohydrate (g/day) 206 216
200 ± 36 218 ± 44
Total Potassium (mg/day)3 2527 2831
2478 ± 522 2846 ± 553
1Adjusted for age, height, weight, total hours of activity/week, alcohol 
consumption and total energy intake 2Groups were stratified to 
below (Group 1) and above (Group 2) the normal cognitive function 
score of 27 3significantly different between groups, P = 0.02BMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/2
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those with more rapid total hip bone loss were more likely
to have a decline in cognitive function than those who
had lower rates of bone loss. It therefore appears based on
the above evidence lower levels of cognitive function are
associated with lower hip BMD. The above researchers did
not measure the whole body, lumbar spine or forearm to
assess their relationship with cognitive function. In our
study, these bone areas were significantly lower in subjects
with lower MMSE scores although the statistical signifi-
cance slightly diminished after the univariate follow-up
tests.
We attribute the diminished difference between the
groups to several factors. First, the average score on the
MMSE in our subjects was 27.9, which is considered nor-
mal cognitive function [24], indicating on average our
subjects were not cognitively impaired. Group 1 (MMSE
score of <27.9) had only 34 subjects, and 10 of them had
a score of 27, which is considered normal. Therefore out
of 97 subjects only 24 had a MMSE score between 22–26
(mild cognitive impairment), and 73 were in the normal
range for cognition. If there were more subjects with mild
cognitive impairment, stronger significant group differ-
ences may have been reached even after the correction
tests. Second, subjects in Group 1 had significantly lower
weight than those in Group 2. Lower weight is associated
with lower bone mass [27,29]. In this data set weight was
a stronger predictor for BMD than MMSE score, and when
entered as a co-variate in MANCOVA, statistical signifi-
cance was diminished in univariate follow-up tests. Third,
the MMSE only measures overall cognitive function.
Measuring verbal memory specifically, similarly to Zhang
et al [1], may have shown a stronger positive relationship
with BMD.
Regarding diet, the main finding was that total potassium
intake was significantly higher in subjects with normal
cognitive function compared to subjects with mild cogni-
tive impairment. When comparing adjusted means, it
appears about 300 mg of additional potassium a day may
positively benefit cognitive function. MANCOVA results
indicated a small effect (η2 = 0.07), or about 7% of gener-
alized variability in both potassium and carbohydrate
intake was accounted for by differences in MMSE scores
after correcting for subjects age, height, weight, total activ-
ity, average daily alcohol consumption and vitamins
intake. Adjusted means for both potassium and carbohy-
drate intake were higher in Group 2 (normal cognitive
function). It is possible that both carbohydrate and total
potassium intake may have served as markers for a diet
higher in fruits and vegetables (excellent sources of both
carbohydrates and potassium). Such kind of diet may
benefit cognitive function in older women. This research
supports the findings of other studies, which found older
people who consume more of the above foods to have
better cognitive function than people who consume less
[9-12]. None of the other nutrients in our study examined
by MANCOVA were significant predictors of cognitive
function.
Saturated fat was a significant negative predictor of MMSE
score in multiple regression analysis, which agrees with
the findings of Ortega et al [9]. They found elderly people
with scores of 28 or higher on the MMSE to have lower
intakes of saturated fat. The Rotterdam study found no
significant relationship with any type of fat in the diet and
risk of dementia or its subtypes in a prospective evalua-
tion in over 5,000 elderly subjects [19]. These subjects had
a normal cognition at baseline and the diet was compared
with the incidence of a diagnosis of dementia after a mean
follow-up of 6 years. However, the researchers did not
measure cognitive function in their subjects so it is not
known whether milder cases of cognitive decline such as
in our study may be related negatively to saturated fat
intake.
There are a few limitations to our study. Although some
variables were expressed as cumulative averages collected
within 2-year period, this is a cross-sectional evaluation
with respect of cognitive functioning that was evaluated
only once. Therefore all findings have to be taken within
that context and within the limitations of cross-sectional
study. Education level was not controlled for, which has
been found to affect individual scores on the MMSE [24].
However, this study population did report having at least
a high school education and many reported having a col-
lege education as well. None of the subjects were currently
using estrogen but 14 reported past estrogen use for a
short time (up to 1 year). The past-estrogen use was not
controlled for, however, in our previous analyses, it did
not influence BMD or MMSE scores for those individuals
[20,27]. We used two criteria for determining the cut-off
levels for MMSE scores on which to stratify subjects into
groups. One was the internal criterion (mean for MMSE
score of 27.9) and was used for the evaluation of the
relationship between BMD and cognition. Another was an
external criterion distinguishing normal from cognitively
impaired subjects (MMSE score of 27) and was used for
the evaluation of the relationship between diet and cogni-
tion. We performed all analyses with each cut-off level,
and although the results were similar, those based on
above described stratification showed slightly higher sig-
nificance and therefore they are reported.
Our study also has several strengths and is distinct with
respect to a comprehensive approach in measuring and
evaluating BMD of various skeletal sites, precise identifi-
cation and inclusion of covariates and analysis of their
independent effect on bone and/or cognition, as well as
the comprehensive dietary and activity assessment. ByBMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/2
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using MANCOVA we were able to simultaneously evalu-
ate all measurable skeletal sites and their relationship
with MMSE scores and consequently strengthen the over-
all conclusion. An important issue in this context is possi-
ble interaction among age, BMD, cognitive function and
dietary intake and physical activity. For example, age
alone may be responsible for both the decline in BMD
and cognitive function, hence the association between the
two. A similar case could be made for dietary intake and
physical activity. In order to overcome these effects, all our
analyses were performed with taking into account the var-
iables that might interact, be co-linear, and/or independ-
ently influence either BMD or cognition. The dietary and
activity assessment was a result of a cumulative average
over a 2-year period. This provides additional strength to
the data and the assurance that both assessments are fairly
accurate and representative of subjects' long term intake
and activity, not necessarily a case in some other studies.
Conclusions
It appears based on the findings of this study and others,
mild degrees of cognitive impairment may be associated
with lower levels of BMD specifically in the hip. Lumbar
spine and forearm BMD seems to be slightly lower (2–
3%) in subjects with lower MMSE scores, based on
adjusted means in our study, but clearly more research is
needed to determine these relationships. Our findings
also indicate a diet containing carbohydrate sources that
are also high in potassium such as fruits and vegetables
may benefit cognitive function, while saturated fat may
influence it negatively. A prudent action (if practical and
possible) may be the evaluation of bone status and dietary
intake in older women presenting with cognitive impair-
ment, for both potential bone loss and poor diet lacking
in good sources of potassium and containing excess
amounts of saturated fat.
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